Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Cleaning Validation of Single-Use Systems – V 2.0

Posted on By


Biosimilars: SOP for Cleaning Validation of Single-Use Systems – V 2.0


Standard Operating Procedure for Cleaning Validation of Single-Use Systems in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/138/2025
Supersedes SOP/BS/138/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the validation strategy and procedure for ensuring cleaning effectiveness of single-use systems (SUS) in biosimilar manufacturing operations and to confirm the absence of cross-contamination risks, extractables, and leachables post-rinsing and usage.

2. Scope

This SOP applies to disposable bioreactor bags, tubing sets, mixers, filters, and bags used in upstream and downstream processing where reuse is practiced under restricted and validated conditions (e.g., tubing manifolds or connector assemblies).

3. Responsibilities

  • Production: Execute cleaning or rinsing procedures on designated SUS components.
  • QC (Chemical & Microbiology): Perform analytical and microbial testing for residues and sterility assurance.
  • QA: Approve cleaning validation protocols and reports and verify compliance.

4. Accountability

The QA Head is accountable for ensuring validated cleaning protocols for all SUS used in GMP operations, aligned with risk-based control strategies and regulatory expectations.

5. Procedure

5.1 Identification of Reusable SUS

  1. Define SUS components eligible for reuse based on:
    • Vendor recommendations
    • Process contact risk
    • Regulatory acceptance (e.g., < 3 reuse cycles)
  2. Document these in Annexure-1: SUS Reuse Assessment Form.

5.2 Cleaning/Rinsing Procedure

  1. Post-use, rinse the SUS component with WFI or buffer (3x volume flush) using closed-loop system.
  2. Perform visual inspection for particulates, discoloration, or fouling.
  3. Capture rinse samples in pre-cleaned containers for TOC, conductivity, and bioburden testing.

5.3 Validation Strategy

  1. Design cleaning validation protocol considering:
    • Worst-case product load
    • Sampling technique (direct contact or rinse)
    • Analytical detection limits
  2. Execute 3 consecutive successful cleanings for each SUS category.
  3. Maintain data in Annexure-2: Cleaning Validation Log.

5.4 Acceptance Criteria

  1. TOC: ≤ 10 ppm
  2. Conductivity: Within 10% of WFI baseline
  3. Bioburden: < 10 CFU/100 mL
  4. No visible residue or blockage

5.5 Documentation and Approval

  1. All validation activities must be documented in the Cleaning Validation Summary Report.
  2. QA must sign off validation and issue a status label/tag on SUS (Valid for Reuse).

6. Abbreviations

  • SUS: Single-Use System
  • TOC: Total Organic Carbon
  • CFU: Colony Forming Units
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. SUS Reuse Assessment Form – Annexure-1
  2. Cleaning Validation Log – Annexure-2

8. References

  • FDA Guidance for Industry: Single-Use Technology
  • EU GMP Annex 15 – Qualification and Validation
  • USP <665>, <1665> – Extractables and Leachables

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: SUS Reuse Assessment Form

SUS ID Component Type Risk Level Reuse Limit Approval Status
SUS-001 Transfer Manifold Low 3 Approved

Annexure-2: Cleaning Validation Log

Date SUS ID TOC (ppm) Conductivity (µS/cm) Bioburden (CFU) Result
03/05/2025 SUS-001 4.2 1.5 0 Pass

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included validation sampling and E&L references Regulatory Update
See also  Biosimilars: SOP for Stable Cell Line Development - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Handling and Storage of Packaging Materials – V 2.0
Next Post: Gel Manufacturing: SOP for Process Validation of Gel Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version